ProQR Therapeutics N.V. (PRQR) PT Lowered to $20 at RBC Capital
Tweet
Share
E-mailGet Alerts PRQR Hot Sheet
Price: $2.22 +3.26%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
RBC Capital analyst Kennan MacKay lowered the price target on ProQR Therapeutics N.V. (NASDAQ: PRQR) to $20.00 (from $22.00) while maintaining a Outperform rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on ProQR Therapeutics N.V. (PRQR)
- Bank of Nova Scotia (BNS:CN) (BNS) PT Raised to Cdn$136 at CIBC
- Wolverine World Wide (WWW) PT Raised to $20 at Williams Trading
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
